BA
CAPR icon

BlackRock Advisors’s Capricor Therapeutics CAPR Stock Holding History

BlackRock Advisors’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4K Hold
167
– – ﹤0.01% 3641
2016
Q3 		$5K Hold
167
– – ﹤0.01% 3638
2016
Q2 		$7K Hold
167
– – ﹤0.01% 3630
2016
Q1 		$4K Hold
167
– – ﹤0.01% 3685
2015
Q4 		$5K Buy
+167
New +$6.64K ﹤0.01% 3715

Other funds holding CAPR

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.62B AUM 36.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's CAPR Position: Q4 2016 in Review

BlackRock Advisors held its Capricor Therapeutics (CAPR) position steady in Q4 2016 at 167 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #3641.

BlackRock Advisors first reported a position in CAPR in Q4 2015 and has held it in 5 quarters since. The position peaked at $7K in Q2 2016. 20 funds tracked by Wall St. Rank hold CAPR as of Q4 2016.

  • BlackRock Advisors held 167 shares of Capricor Therapeutics worth $4K as of Q4 2016.
  • BlackRock Advisors left its Capricor Therapeutics share count unchanged in Q4 2016.
  • Capricor Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3641 holding.
  • BlackRock Advisors first reported a position in Capricor Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • BlackRock Advisors's Capricor Therapeutics position peaked at $7K in Q2 2016.
  • 20 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.